DocGo (DCGO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.27, -3.72% vs the prior close of $0.28.
- Volume 1.06M shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DCGO slides 3.7% to $0.27, a 52-week low. Closed at $0.27, -3.72% vs the prior close of $0.28. Day range $0.25β$0.30, opened at $0.27.
DCGO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β DCGO slides 3.7% to $0.27, a 52-week low
- Closed at $0.27, -3.72% vs the prior close of $0.28. Day range $0.25β$0.30, opened at $0.27.
- Volume was 1.06M shares, 1.3x its 50-day average of 812.17K.
- Price is -33.5% vs its 50-day average ($0.41) and -55.0% vs its 200-day average ($0.60).
- 52-week range $0.24β$1.65; today's close sits at 2% of that range, 83.5% below the 52-week high.
Oct 15, 2026 β DCGO jumps 3.7% to $0.28
- Closed at $0.28, +3.68% vs the prior close of $0.27. Day range $0.24β$0.28, opened at $0.27.
- Volume was 989.80K shares, 1.2x its 50-day average of 798.66K.
- Price is -32.1% vs its 50-day average ($0.42) and -53.5% vs its 200-day average ($0.61).
- 52-week range $0.24β$1.65; today's close sits at 3% of that range, 82.9% below the 52-week high.
Oct 14, 2026 β DCGO slides 10.8% to $0.27, a 52-week low, 10 down days in a row
- Closed at $0.27, -10.82% vs the prior close of $0.31. Day range $0.27β$0.32, opened at $0.31.
- Volume was 1.22M shares, 1.6x its 50-day average of 779.79K.
- Price is -35.6% vs its 50-day average ($0.42) and -55.3% vs its 200-day average ($0.61).
- 52-week range $0.27β$1.65; today's close sits at 0% of that range, 83.5% below the 52-week high.
- That makes 10 straight losses.
Oct 13, 2026 β DCGO slides 8.7% to $0.31, a 52-week low, 9 down days in a row
- Closed at $0.31, -8.68% vs the prior close of $0.33. Day range $0.30β$0.34, opened at $0.33.
- Volume was 632.10K shares, 0.8x its 50-day average of 774.90K.
- Price is -29.1% vs its 50-day average ($0.43) and -50.2% vs its 200-day average ($0.61).
- 52-week range $0.30β$1.65; today's close sits at 0% of that range, 81.5% below the 52-week high.
- That makes 9 straight losses.
Oct 12, 2026 β DCGO dips 1.2% to $0.33, a 52-week low, 8 down days in a row
- Closed at $0.33, -1.18% vs the prior close of $0.34. Day range $0.33β$0.34, opened at $0.34.
- Volume was 231.20K shares, 0.3x its 50-day average of 772.95K β lighter than usual.
- Price is -23.6% vs its 50-day average ($0.44) and -45.7% vs its 200-day average ($0.62).
- 52-week range $0.31β$1.65; today's close sits at 2% of that range, 79.8% below the 52-week high.
- That makes 8 straight losses.
Oct 9, 2026 β DCGO ends flat (-0.3%) to $0.34, a 52-week low, 7 down days in a row
- Closed at $0.34, -0.29% vs the prior close of $0.34. Day range $0.33β$0.35, opened at $0.34.
- Volume was 196.70K shares, 0.3x its 50-day average of 774.88K β lighter than usual.
- Price is -23.7% vs its 50-day average ($0.44) and -45.3% vs its 200-day average ($0.62).
- 52-week range $0.31β$1.65; today's close sits at 2% of that range, 79.5% below the 52-week high.
- That makes 7 straight losses.
Oct 8, 2026 β DCGO dips 1.7% to $0.34, a 52-week low, 6 down days in a row
- Closed at $0.34, -1.74% vs the prior close of $0.34. Day range $0.33β$0.35, opened at $0.34.
- Volume was 481.10K shares, 0.6x its 50-day average of 776.31K.
- Price is -24.6% vs its 50-day average ($0.45) and -45.4% vs its 200-day average ($0.62).
- 52-week range $0.31β$1.65; today's close sits at 2% of that range, 79.5% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 β DCGO slides 4.7% to $0.34, 5 down days in a row
- Closed at $0.34, -4.70% vs the prior close of $0.36. Day range $0.34β$0.36, opened at $0.35.
- Volume was 534.20K shares, 0.7x its 50-day average of 774.63K.
- Price is -24.4% vs its 50-day average ($0.46) and -44.7% vs its 200-day average ($0.62).
- 52-week range $0.31β$1.65; today's close sits at 3% of that range, 79.1% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 β DCGO dips 0.8% to $0.36, 4 down days in a row
- Closed at $0.36, -0.82% vs the prior close of $0.37. Day range $0.35β$0.38, opened at $0.37.
- Volume was 321.60K shares, 0.4x its 50-day average of 777.13K β lighter than usual.
- Price is -21.6% vs its 50-day average ($0.46) and -42.2% vs its 200-day average ($0.63).
- 52-week range $0.31β$1.65; today's close sits at 4% of that range, 78.1% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 β DCGO dips 1.4% to $0.37, 3 down days in a row
- Closed at $0.37, -1.35% vs the prior close of $0.37. Day range $0.37β$0.38, opened at $0.38.
- Volume was 225.30K shares, 0.3x its 50-day average of 788.45K β lighter than usual.
- Price is -21.9% vs its 50-day average ($0.47) and -42.0% vs its 200-day average ($0.63).
- 52-week range $0.31β$1.65; today's close sits at 4% of that range, 77.9% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 2, 2026 β DCGO slides 6.1% to $0.37
- Closed at $0.37, -6.09% vs the prior close of $0.39. Day range $0.36β$0.40, opened at $0.40.
- Volume was 333.30K shares, 0.4x its 50-day average of 786.69K β lighter than usual.
- Price is -21.6% vs its 50-day average ($0.47) and -41.5% vs its 200-day average ($0.63).
- 52-week range $0.31β$1.65; today's close sits at 4% of that range, 77.6% below the 52-week high.
DCGO latest news & SEC filings
Every SEC filing by or about DCGO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 1.02 β Ended a material agreement.
- Item 2.03 β Took on a new material debt or financial obligation.
- Item 3.02 β Sold unregistered shares.
- Item 8.01 β Reported other events the company considers important.
Aug 17, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $73.42M (prior year $80.42M) (-8.7% vs Jun 30, 2025)
- Net income: -$15.82M (prior year -$11.16M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.11) (loss widened vs Jun 30, 2025)
Aug 17, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 10, 2026 Β· Form NT 10-Q β Notice of late quarterly report
Notice of late quarterly report
Jul 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Jul 28, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade DCGO
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 16, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.50% (largest 10.8%). That is a volatile stock.
- Liquidity: about 665.15K shares (β$180.59K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.27 vs a range of $0.24β$1.65 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Ely D Tendler sold 16,850 shares on Dec 15, 2025.
- Latest filings: 8-K Oct 5, 2026; 10-Q Aug 17, 2026; 8-K Aug 17, 2026.
- Share count: 98.93M shares outstanding (Aug 14, 2026), +1.1% vs a year earlier.
- Listing: Nasdaq Β· industry: Services-Health Services.
DCGO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.27 | 0.30 | 0.25 | 0.27 | 1.06M |
| Oct 15, 2026 | 0.27 | 0.28 | 0.24 | 0.28 | 989.80K |
| Oct 14, 2026 | 0.31 | 0.32 | 0.27 | 0.27 | 1.22M |
| Oct 13, 2026 | 0.33 | 0.34 | 0.30 | 0.31 | 632.10K |
| Oct 12, 2026 | 0.34 | 0.34 | 0.33 | 0.33 | 231.20K |
| Oct 9, 2026 | 0.34 | 0.35 | 0.33 | 0.34 | 196.70K |
| Oct 8, 2026 | 0.34 | 0.35 | 0.33 | 0.34 | 481.10K |
| Oct 7, 2026 | 0.35 | 0.36 | 0.34 | 0.34 | 534.20K |
| Oct 6, 2026 | 0.37 | 0.38 | 0.35 | 0.36 | 321.60K |
| Oct 5, 2026 | 0.38 | 0.38 | 0.37 | 0.37 | 225.30K |
| Oct 2, 2026 | 0.40 | 0.40 | 0.36 | 0.37 | 333.30K |
| Oct 1, 2026 | 0.39 | 0.41 | 0.38 | 0.39 | 466.40K |
| Sep 30, 2026 | 0.38 | 0.42 | 0.38 | 0.40 | 652.10K |
| Sep 29, 2026 | 0.37 | 0.39 | 0.35 | 0.37 | 561.90K |
| Sep 28, 2026 | 0.34 | 0.39 | 0.34 | 0.37 | 917.30K |
| Sep 25, 2026 | 0.34 | 0.35 | 0.34 | 0.34 | 513.20K |
| Sep 24, 2026 | 0.36 | 0.36 | 0.31 | 0.34 | 2.20M |
| Sep 23, 2026 | 0.36 | 0.37 | 0.35 | 0.36 | 148.50K |
| Sep 22, 2026 | 0.36 | 0.38 | 0.34 | 0.36 | 1.16M |
| Sep 21, 2026 | 0.37 | 0.38 | 0.36 | 0.36 | 462.40K |
About DocGo
DocGo (DCGO) is listed on the Nasdaq and classified by the SEC under βServices-Health Servicesβ. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1822359.
DCGO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lee Bienstock | Chief Executive Officer | May 14, 2026 |
| Michael J Burdiek | Director | Dec 16, 2025 |
| Etalvina Leite | Director | Dec 16, 2025 |
| Ira Smedra | Director | Dec 16, 2025 |
| James M Travers | Director | Dec 16, 2025 |
| Ely D Tendler | General Counsel and Secretary | Dec 16, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lee Bienstock | Chief Executive Officer | May 14, 2026 |
| Norman Rosenberg | CFO and Treasurer | Dec 16, 2025 |
| Stephen Sugrue | Chief Compliance Officer | Dec 16, 2025 |
| Ely D Tendler | General Counsel and Secretary | Dec 16, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 15, 2025 | Ely D Tendler | Sale | 16,850 | $0.91 |
| Dec 15, 2025 | Ely D Tendler | Sale | 16,850 | $0.91 |
| Dec 15, 2025 | Ely D Tendler | Sale | 16,850 | $0.91 |
| Dec 15, 2025 | Ely D Tendler | Sale | 16,850 | $0.91 |
DCGO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $322.20M | $-182.40M | -1.84 | $34.45M |
| Dec 31, 2024 | $616.56M | $19.99M | 0.18 | $70.12M |
| Dec 31, 2023 | $624.29M | $6.86M | 0.06 | $-64.49M |
| Dec 31, 2022 | $440.52M | $34.58M | 0.34 | $28.87M |
| Dec 31, 2021 | $318.72M | $23.74M | 0.25 | $-1.95M |
Latest balance sheet: total assets $186.82M, total liabilities $91.04M, cash $25.23M (as of Jun 30, 2026).
DCGO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $0.71 |
| May 11, 2026 | 8-K Item 2.02 (results) | $0.59 |
| Mar 16, 2026 | 8-K Item 2.02 (results) | $0.65 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $1.11 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.39 |
| May 8, 2025 | 8-K Item 2.02 (results) | $2.33 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $3.92 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $3.61 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | β |
| May 8, 2024 | 8-K Item 2.02 (results) | β |
| Feb 28, 2024 | 8-K Item 2.02 (results) | β |
| Jan 16, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Services-Health Services
GeneDx (WGS)LifeStance Health (LFST)Privia Health (PRVA)Omada Health (OMDA)U S Physical Therapy (USPH)Pennant (PNTG)InnovAge (INNV)Strata Critical Medical (SRTA)EUDA Health (EUDA)Agape ATP (ATPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DCGO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.